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M A J O R A R T I C L E
HTLV-2B Strains, Similar to Those Found in
Several Amerindian Tribes, Are Endemic in
Central African Bakola Pygmies
Philippe Maucle`re,1,a Philippe Vicente Afonso,1,a,b Laurent Meertens,1,a Sabine Plancoulaine,1,3 Sara Calattini,1
Alain Froment,4 Monique Van Beveren,1 Guy de The´,1 Lluis Quintana-Murci,2 Renaud Mahieux,1,c and Antoine Gessain1
1Unite´ d'Epide´miologie et Physiopathologie des Virus Oncoge`nes, 2Human Evolutionary Genetics, Institut Pasteur, 3Laboratoire de Ge´ne´tique Humaine
des Maladies Infectieuses, Institut National de la Sante´ et de la Recherche Me´dicale, and 4Institut de Recherche pour le De´veloppement, Muse´e de
l'Homme, Paris, France; and 5Centre Pasteur du Cameroun, Yaounde´, Cameroun
Background. The presence and origin of endemic foci of human T-lymphotropic virus type 2 (HTLV2)
infection in Africa remain a matter of debate.
Methods. To better appreciate such determinants, we performed a survey of 1918 inhabitants from Cameroon
forest areas, including 1051 Bakola Pygmies and 867 Bantus.
Results. The overall HTLV-1/2 seroprevalence was 4% (49 cases of HTLV-1 and 27 cases of HTLV-2 infection).
Both infections were mainly restricted to the Bakola Pygmies, with surprisingly no HTLV-2 infections in the Bantu
population. Both HTLV-1 and HTLV-2 seroprevalences increased with age. There was evidence of ongoing HTLV-2
transmission in this population. Lymphoid T cell lines producing HTLV-2 were established. HTLV-2 long terminal
repeat sequences (672 base pairs) obtained from 7 infected Bakola were highly similar to each other (,1%
nucleotide divergence), as well as to Amerindian HTLV-2B strains. Analyses on a complete sequence (8954 base
pairs) confirmed that it was a typical HTLV-2 subtype B strain. Along with molecular clock analysis, these data
strongly suggest that HTLV-2 has been endemic in the Bakola Pygmy population for a long time.
Conclusions. This study demonstrates clearly an HTLV-2 endemicity with ongoing transmission in an African
population. Furthermore, it give insights into central questions regarding the origins and evolution rate of HTLV-2
and the migrations of infected populations.
HumanT-lymphotropic virus type 1 (HTLV-1), simianT-
lymphotropic virus type 1 (STLV-1), HTLV-2 [1], STLV-
2, STLV-3, and the recently discoveredHTLV-3 [2, 3] and
HTLV-4 [3] constitute a group of related human and
simian retroviruses, the primate T-lymphotropic viruses
(PTLVs), that share common biological and molecular
features. HTLV-1 is the causative agent of adult T cell
leukemia/lymphoma and of tropical spastic paraparesis/
HTLV-1–associated myelopathy (TSP/HAM). By con-
trast, HTLV-2, which also has some transforming
capacities in vitro, has been in vivomainly associated with
TSP/HAM–like diseases [4] and with lymphocytosis [5].
A striking characteristic of HTLV-1 and HTLV-2
epidemiology is the presence of clusters of high preva-
lence, often located near regions of low endemicity [6].
High HTLV-1–endemic clusters have thus been de-
scribed in areas of southern Japan and Gabon, as well as
in populations of African origin in French Guyana and
Colombia [7]. Similarly, HTLV-2 is endemic among
several, often remote, Amerindian tribes [4, 8–11]. There
is also evidence for a 30-year-old epidemic of HTLV-2
infection among intravenous drug users, mainly in the
United States but also in Europe [4, 12–14]. Despite
these differences, both retroviruses share similar epide-
miological determinants: higher prevalence in women,
increase with age, and similar modes of transmission,
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including mother-to-child transmission by prolonged breast-
feeding [4, 6].
The origin of the puzzling geographical (or often ethnic)
distribution of HTLV-1 and -2 is unclear. It is probably
linked to a founder effect followed by persistent viral trans-
mission in specific populations. The latter may be favored by
genetic background, as well as cultural and environmental
cofactors.
Most strains of PTLV-1 cannot be separated into distinct
phylogenetic lineages according to their origin species. In Central
Africa, STLV-1 strains from chimpanzees or mandrills cannot be
distinguished from HTLV-1 strains of molecular subtype B and
D, respectively [7, 15, 16]. This phylogenetic intermixing has
been interpreted as evidence for past and recent interspecies
transmission episodes [15, 17]. The situation for PTLV-2 is dif-
ferent: HTLV-2 and STLV-2 form distinct monophyletic clades,
with no evidence for recent interspecies transmissions [17, 18].
Molecularly, the HTLV-2 sequences are subdivided in 2 major
subtypes (A and B); both have been found in Amerindians and
intravenous drug–using populations. Subtype B is referred to as
the paleo-Indian subtype [6, 9, 11, 19, 20]. A variant of subtype
A (called subtype C) is nearly exclusive in Brazilian populations
[4, 21].
As a consequence, HTLV-2 was originally thought to be
a New World–restricted virus, brought to the Americas through
the migration of the original Mongoloid settlers through the
Bering Strait some 25,0006 15,000 years ago [17, 18]. However,
sporadic cases of HTLV-2 infection, with limited molecular
characterization, were described in different African areas [22–
25], which complicated the overall picture. Furthermore, in
1998, a unique highly variant strain (called subtype D) was
characterized from an Efe Pygmy living in the Democratic
Republic of Congo (DRC) [26]. The nucleotide divergence be-
tween HTLV-2D, -2A, and -2B viruses (corresponding to a
estimated divergence earlier than 40,000 years ago) could
suggest an African origin for HTLV-2 [18]. We then isolated
a HTLV-2 subtype B strain (Pygcam-1) from a Bakola Pygmy
living in Cameroon [27]. This virus was mostly identical to
HTLV-2 sequences found in Amerindian populations, pointing
at such issues as HTLV-2 origins and evolution rate [17, 27, 28].
The molecular data concerning these ‘‘African’’ HTLV-2
strains remained limited, as they were based mostly on analyses
of sporadic cases. In fact, one could always argue about a recent
introduction of HTLV-2 in Africa. Its endemic presence
remained to be demonstrated.
To get new insights into epidemiological determinants and
origins of HTLV-2 in Africa, we developed a cross-sectional
study among Bantus and Bakola populations living in the
Southern Cameroon rain forest area. We therefore assessed the
overall HTLV-1 and -2 seroprevalence in these populations and
compared the main epidemiological determinants of HTLV-1
and HTLV-2–infected Bakola and Bantu populations. We also
isolated and characterized several new HTLV-2 strains that we
integrated into phylogenetic and molecular clock studies.
METHODS
Population Studied
Bakola Pygmies are an ethnic group of around 5000 individuals,
living mainly in the Ocean Region in South Cameroon (Sup-
plemental Figure 1). This group is spread throughout the rain
forest territories. They were traditionally hunter-gatherers but
now practice rudimentary agriculture and trade with neigh-
boring Bantu farmers [29].
Between 1994 and 1998, a series of missions were conducted
in several settlements of Bakola, as well as in surrounding Bantu
villages. A 5-mL blood sample was taken on EDTA for each
participant. The overall study was completed after authorization
by the national (Ministry of Health) and local (village/settlement
chiefs) authorities and personal consent of every participant (or
parental consent for minors).
HTLV-1 and -2 Serological Tests
Plasma samples were screened for antibodies against HTLV-1
and -2 with enzyme-linked immunosorbent assay (ELISA)
(Platelia HTLV NEW, Sanofi Diagnostic Pasteur), as well as an
in-house indirect fluorescent antibody (IFA) test [27]. A con-
firmatory Western blot (HTLV 2.3, Diagnostic Biotechnology)
was performed on samples found positive and/or borderline in
ELISA and IFA testing with stringent criteria to define HTLV-1
or -2 seropositivity.
Viral Detection and Isolation
Peripheral blood mononuclear cells (PBMCs) were cultured
[27]. Indirect IFA and cytofluorographic analyses were per-
formed on these cells [30]. Production of p24 antigen was de-
tected by means of ELISA (Coulter).
Polymerase Chain Reaction
DNA was extracted, either from buffy-coats or from PBMCs
(cultured or not). Polymerase chain reaction (PCR) tests for the
HTLV pol fragment were carried out with the SK110-SK111
primers [31]. A Southern blot was then performed on the am-
plified DNA using either SK112 (for HTLV-1) or SK188 (for
HTLV-2) as labeled probes.
Seven 672 base-pair–long terminal repeat (LTR) fragments
were amplified using the primers BSDR4-BSQF2 and sequenced
[32]. The complete sequence (8955 base pairs) of 1 HTLV-2
strain was obtained after PCR amplification, cloning, and se-
quencing of 9 distinct proviral fragments.
Phylogenetic and Molecular Clock Analyses
Multiple alignments were obtained with the DAMBE
(University of Ottawa) program. They were then submitted to
the Modeltest program (University of Vigo) (version 3.6) to
select the best model to apply to phylogenetic analyses. These
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parameters were implemented in the PAUP program (version
4.0b10) to infer trees according to the neighbor-joining or
maximum likelihood methods. To test the robustness of the tree
topologies, 1000 bootstrap replicates were performed.
Molecular clock analyses were performed on the HTLV-2
LTR alignment. The evolutionary rate was estimated by using
a Bayesian Markov chain Monte Carlo (MCMC) molecular
clock method using the BEAST software package [33]. Both
strict and relaxed molecular clock hypotheses gave similar evo-
lutionary rates. The general time-reversible substitution model
(gamma plus invariant sites) of 6 gamma categories was used.
The population size was considered constant, ranging from 0 to
100,000,000 [28]. The chain length fromMCMC analysis was 20
million, with sampling every 10,000 steps. The divergence dates
were systematically determined for the monophyletic groups of
interest, a priori introduced in the BEAST program. Conver-
gence of the MCMC was assessed by calculating the effective
sampling size (ESS) with the program Tracer. All parameter
estimates showed significant ESSs (.150).
Statistical Analysis
Proportions were compared using the 2-sided v2 test or
Fisher exact test when needed. To best fit the data, age was log-
transformed. Geometric means of the titers were compared
using a 2-sided paired Student t test. All analyses were
performed using SAS software, version 9.1 (SAS Institute).
RESULTS
Bakola Pygmy Population, But Not Bantu, Infected With HTLV-2
The survey was performed among 1918 persons (1011
women and 907 men; mean age, 32.8 years [range, 2–83 years])
(Figure 1). The studied populations included 1051 Bakola
Pygmies (561 women, 490 men) and 867 Bantus (450
women, 417 men).
Detection of HTLV Infection by Means of Serological
Analyses. Among the 1918 samples tested, 680 samples had
positive results at ELISA, and 320 had either clearly positive or
uncertain (reactive but with a high background) results at IFA
testing. All 759 samples with positive or uncertain seror-
eactivities by means of ELISA and/or IFA testing were tested by
Western blot. Typical HTLV-2 pattern was detected for 27
plasma samples, whereas 49 exhibited a complete HTLV-1
reactivity pattern. However, most (591) of the plasma samples
exhibited a partial reactivity pattern, with indeterminate
profiles; these were considered HTLV-seronegative in the
statistical analysis. Many (187) of these had a typical HTLV gag-
indeterminate pattern, probably a marker of Plasmodium
falciparum infection [31]. The 92 remaining plasma samples
showed no Western blot reactivity.
Confirmation of the Reliability of Serological Studies by
Means of PCR Studies. DNA samples from 336 different in-
dividuals, for whom we had available buffy-coats or PBMCs,
were extracted and then tested using HTLV-1 and -2 pol pri-
mers. Twenty-one originated from the HTLV-2–seropositive
persons and 17 from the HTLV-1–seropositive individuals.
The 298 other samples were from persons with an indeterminate
(n5 158) or a negative (n5 140)Western blot result. There was
a perfect concordance between serological and PCR results,
except for 4 samples. On one hand, proviral DNA could not be
Figure 1. Human T-lymphotropic virus (HTLV) seroprevalence is higher
among Bakola Pygmies than among Bantus. The seroprevalence rates
were given with a 95% confidence interval according to age among 1051
Bakola Pygmies (dark gray) and 867 Bantus (light gray).
Figure 2. Both human T-lymphotropic virus type 1 (HTLV-1) and HTLV-2
are endemic among Bakola Pygmies. HTLV-1 (light gray) and HTLV-2 (dark
gray) seroprevalence rates are given with a 95% confidence interval
among 1051 Bakola Pygmies from Cameroon, Central Africa. HTLV-1 and
HTLV-2 antibody titers were obtained using indirect fluorescent antibody
testing by 2-fold serial dilution. HTLV-1–positive plasma samples were
more reactive on MT2 cells than on C19 cells (geometric mean of the
titers, 1/55 vs 1/23; P, .001), whereas HTLV-2–positive plasma samples
were more reactive on C19 than on MT2 cells (1/57 vs 1/11; P , .001).
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amplified for 1 person with a typical HTLV-2 Western blot
result; on the other hand, 3 individuals with an indeterminate
Western blot result were positive by means of PCR for HTLV-1
(2 cases) or HTLV-2 (1 case). This confirms that the strategy
that we followed is appropriate for large epidemiological studies;
it also shows that we might be slightly underestimating the
retroviral prevalence.
Comparison of the Epidemiological Features of HTLV-1
and HTLV-2 Infection. Among the 1918 plasma samples
tested, the overall HTLV-1/2 seroprevalence was 4% (n 5 76).
HTLV-1/2 infection was significantly more frequent among the
Bakola than among the Bantus (6.1% vs 1.3%; P, .001) (Figure
1). Surprisingly, HTLV-2 infection was restricted to the Bakola
population (2.6%, ie, 27 HTLV-2–positive individuals; P ,
.001) (Figure 2). Among this group, seroprevalence increased
with age for both viruses, reaching 11.3% for HTLV-1 and 6.5%
for HTLV-2 in the elderly (.60 years old) (Figure 2). Although
HTLV-2 infection was more prevalent in women than in men
(P 5 .03), this was not the case for HTLV-1 (P 5 .22).
Geographical analysis indicated a wide distribution of HTLV-1
and HTLV-2–infected individuals in the different territories of
the Bakola (Supplemental Figure 1).
HTLV-2 Is Still Being Transmitted in the Bakola
Population. The presence of HTLV-2 in few children,
together with the analysis of some genealogical trees showing
familial clusters (husband-wife and mother-child) (Supple-
mental Figure 2), indicates an ongoing transmission of HTLV-2
within this population.
To isolate the virus, PBMCs from 7 HTLV-2–seropositive
Pygmies were cultured. In 6 cases, cells proliferated rapidly, and
after 2–3 weeks some very large cells were detected. These were
positive by IFA test for HTLV, and HTLV-1/2 p24 antigen was
detected in the supernatant of these cultures. After 2 months of
culture, 10%–60% of cells were HTLV positive by IFA. These
cells had an activated T cell phenotype (CD21, CD31, CD 19–,
HLA DR1, CD251) and were either CD41 or CD81 or had both
markers. Three cultures were further expanded and cocultivated
with BJAB cells. After 3–5 days, expanding HTLV-2–positive
syncitia were observed.
Similarity of the HTLV-2B Strains Endemic in Bakola
Pygmies to Those Present in Some Amerindian Populations
Phylogenetic Analysis of LTR Sequences. LTR fragments (625
base pairs) were obtained from 7 Bakola who were living in 4
independent settlements. The sequences were very similar to
each other and to the Pygcam-1 strain [27]: nucleotide genetic
divergence was lower than 1.2%. With the exception of the
Pygcam-1 and Gab strains [34], the HTLV-2B clade used to be
composed exclusively of Amerindian sequences (Figure 3).
Surprisingly, the new Pygmy strains showed a high similarity to
these Amerindian strains (0%–1.2% divergence). Moreover,
neither the Bakola nor the Amerindian strains constituted
a separate monophyletic clade within the B-subtype (Figure 3).
Phylogenetic Analysis of Complete Sequences. A complete
proviral sequence (8955 base pairs) was obtained from Bakola
Pygmy PYG550602. Phylogenetic analysis performed on the
concatenated gag-pol-env-tax genes (7263 base pairs) confirmed
that the new sequence is unique and belongs to the HTLV-2B
subgroup (Figure 4).
Molecular Clock Analysis. The evolution rate of retro-
viruses can be widely variable. It can depend on the virus itself:
PTLV-1 and PTLV-2 have different evolution rates [18], sup-
posedly because of different replication strategies. The evolution
rate can also depend on the host species [35]. Finally, the evo-
lution rate of HTLV-2 is different between individuals who do
and do not use intravenous drugs [28, 36]. For these reasons,
we chose to perform the molecular clock analysis on HTLV-2
LTR sequences isolated only from individuals who do not use
intravenous drugs.
We tested 2 different hypotheses for the calibrating date of the
molecular clock using only HTLV-2 sequences:
Figure 3. Strains from Bakola Pygmies belong to the human
T-lymphotropic virus type 2B (HTLV-2B) subgroup. Phylogenetic tree
generated with the neighbor-joining method, performed in the PAUP
program (version 4.0b10), on a 629 base pair fragment of the LTR using
the endemic sequences (from human immunodeficiency virus–negative
individuals) available in GenBank and the 7 new LTR sequences from the
Bakola Pygmy strains obtained in this study (noted as Pygxxxxxx in the
figure and referenced as sequences GU212848-GU212853 in GenBank).
Bootstrap support (1000 replicates) is noted on the branches of the tree.
The tree was rooted with simian T-lymphotropic virus type 2 (STLV-2)
sequences. The branch lengths are drawn to scale, with the bar indicating
0.1 nucleotide replacement per site.
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1. The HTLV-2 groups contain the HTLV-2D sequence,
which is believed to be of African origin, and the HTLV-2A/C
sequences, which are believed to be of Amerindian origin.
Therefore, the divergence date of the HTLV-2 group might be
100,000 6 25,000 years ago, corresponding to the date of
human spread out of Africa;
2. Because HTLV-2A and HTLV-2C contain only
Amerindian sequences, the common ancestor might have
emerged at 25,000 6 5000 years ago, which is the date of
human migrations over the Bering Strait.
Both hypotheses gave very similar dates for the emergence of the
HTLV-2 B subtype: 24,000 6 500 years ago (ESS 5 2904) and
26,000 6 300 years ago (ESS 5 2832), respectively (Figure 5).
DISCUSSION
The Bakola Pygmies are one of the very few populations in
which both HTLV-1 and HTLV-2 are naturally endemic. Pre-
viously, only intravenous drug–using groups had been shown to
be infected by both retroviruses [12, 37]. Our study is the first, to
our knowledge, to show that HTLV-2 endemicity, with ongoing
viral transmission, is clearly established in a large African pop-
ulation. Surprisingly, HTLV-2 strains isolated in Bakola are
nearly identical to strains isolated from several populations of
Native Americans living in different areas of the Americas [6, 9–
11, 17–19]. Such unexpected findings raise several questions.
Why Is the Level of HTLV-1 and HTLV-2 Infection Much Higher in
the Bakola Pygmy Than in the Bantu Populations Living Nearby?
The causes of a retroviral endemic focus restricted to the Bakola
are not clear. The focus might result from a founder effect fol-
lowed by persistent viral transmission facilitated by environ-
mental or cultural situations. Such a hypothesis has been
proposed to explain several HTLV-1 endemic foci [6], as well as
the presence of HTLV-2 found in several Native American
populations [4, 8].
The risk of interspecies transmission seems higher for Bakolas
than for Bantus: the first are hunter-gatherers, whereas the latter
are mostly farmers. One could argue that Bantus also hunt.
However, among Bakola, the majority of men and many women
actively hunt and butcher nonhuman primates [29]. In contrast,
in Bantu populations, the hunting activity is restricted to
few men. Therefore, the cumulative risk of encountering STLV-
infected nonhuman primates and acquiring PTLV is higher in
Bakola than in Bantu populations.
Retroviruses might also have a higher probability of being
maintained among Bakolas than among Bantus. In fact, an-
thropological studies have revealed that duration of breast-
feeding, a major factor for HTLV vertical transmission, is much
longer for Pygmies (often reaching 2–3 years) than in Bantu
populations. Moreover, intimate contacts between Pygmies and
Bantus are very limited, mainly restricted to few episodes of
sexual intercourse between Bantu men and Pygmy women. In
fact, recent genetic studies based on mitochondrial DNA in-
dicated that only Pygmy-to-Bantu maternal gene flow occurred
[38]. As HTLV-1 and -2 seem preferentially transmitted from
men to women [4, 39], such rare contacts are likely not to spread
HTLVs outside the Pygmy community.
Where Did the Bakola Pygmies Acquire HTLV-2?
It is unlikely that interspecies transmission of STLV-2/HTLV-2
to Bakola happened in Cameroon. In fact, despite intensive
searching, no STLV-2–infected monkeys have ever been found
in Cameroon. By contrast, in regions where HTLV-1 and
HTLV-3 infection were found, studies performed on bush-meat
samples or wild-caught live animals have revealed the presence
of STLV-1 and STLV-3 [40–42]. Moreover, despite screening
.15,000 individuals from Cameroon, no investigators have
described HTLV-2 infection apart from in the Bakola [3, 43, 44].
Genetic studies showed that most Pygmy groups located in
Cameroon/Gabon form a homogeneous population, whose an-
cestors separated from the ancestors of farming populations
around 60,000 years ago [38]. However, the origin of the Bakola
population remains unclear. On the basis of their oral tradition,
they might originate from the northwestern part of DRC, where
Figure 4. The strain from the Bakola Pygmy Pyg550602 belongs to the
human T-lymphotropic virus type 2 (HTLV-2) genotype. The phylogenetic
tree was generated with the neighbor-joining method, using 7263 base
pairs of the concatenated gag-pol-env-tax genes of the new Pyg550602
strain obtained in this study (Pyg550602; GenBank accession no.
GU212854) and all the complete sequences of HTLV-1 and HTLV-2
available in GenBank. Bootstrap values (1000 replicates) are noted on the
branches of the tree. Branch lengths are drawn to scale, and the bar
indicates a 0.1-nucleotide substitution per site.
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the few epidemiological surveys that have been performed
showed sporadic cases of HTLV-2 infection [22, 45]. Thus, the
ancestors of the present-day Bakola could have acquired HTLV-2
either in their region of origin or during their migration to their
present-day region of living. Such a hypothesis has been proposed
to explain how Aboriginal groups of Melanesian origin acquired
HTLV-1, although no nonhuman primates have ever lived in
Melanesia [46]. Their ancestors certainly acquired the virus
through zoonotic interspecies transmission from STLV-1–
infected macaques in southeast Asia prior to their migration [47].
How Can HTLV-2B in Pygmies Be So Similar to Amerindian
Strains?
Until now, the HTLV-2A/C and -2B subtypes were supposed to
have originated from the Americans. Indeed, these strains were
found to be endemic in Native American populations scattered
all over the Americas [4, 8–11]. The few previous reports of
sporadic HTLV-2 infection in Africa were thus supposed to re-
sult mainly from recent viral introduction either by infected
Native Americans or, rather, by individuals previously in contact
with infected Native Americans.
Previous studies indeed suggested that the separation
between the original Bakola strain Pygcam-1 and the Seminole
Amerindian strain SEM1050 had occurred only 400 years ago
and that the separation from the Wayu strain WY100 (from
a Colombian Amerindian) occurred evenmore recently [18, 28].
In 1 study, Salemi et al calibrated the molecular clock analysis by
considering the evolution rate from all PTLV strains originating
from individuals who do not use intravenous drugs to be
identical [18]. However, as mentioned previously and revealed
in that very study, the first hypothesis seems to be inadequate. In
the other study, the authors considered the HTLV-2A and -2B
subtypes to be all of Amerindian origin [28]. In such a model,
the divergence for the whole HTLV-2 group (-2A, -2B, and 2D)
occurs around 40,000 years ago, although, because HTLV-2D is
supposed to be African, the date should be prior to the ‘‘out of
Africa’’ period. The authors proposed then that the virus might
just reflect a recent acquisition from a simian host. However,
even if there is no proof for the ancestral presence of HTLV-2D
among humans, there is also no argument to support the
opposite hypothesis.
We demonstrate, however, that HTLV-2B is endemic among
Bakola Pygmies. Interestingly enough, HTLV-2B strains were
also sporadically found in adults living in different unconnected
rural areas, located hundreds or even a few thousand miles apart
in DRC and Gabon [22, 45]. This indicates clearly that HTLV-2B
is spread throughout Central Africa, thus challenging the dogma
about the Native American origin of the HTLV-2B subtype.
Figure 5. Molecular clock analyses and evolution times of human T-lymphotropic virus type 2 (HTLV-2). Molecular-clock analysis was performed on an
alignment of long terminal repeat sequence from HTLV-2 previously obtained using the general time-reversible substitution model implemented with
BEAST software from the University of Oxford, Oxford, UK. We used 2 different hypotheses for the calibration of the time scale (shown in boldface, in
thousands of years). On the left, we supposed that the HTLV-2 group might have radiated when the population spread out of Africa. On the right, we
supposed that the divergence between HTLV-2A and -2C corresponds to the migration over the Bering Strait. The values are given in thousands of years
(values in parentheses correspond to the effective sampling size). For graphical convenience, the lengths of the branches are not strictly proportional to
the divergence times, and the tree has been rooted with simian sequences (even though these were not considered in the molecular clock per se).
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We propose instead that the HTLV-2B group has an African
origin. This hypothesis has been challenged by a molecular clock
calibrated with 2 different but likely calibration dates using
HTLV-2 sequences: (1) the origin of the HTLV-2 type corre-
sponds to the ‘‘out of Africa’’ event, estimated at 100,000
years ago, as it contains the HTLV-2D African Efe sequence;
and (2) the HTLV-2 A/C group, as only composed of Native
Amerindian sequences, may have diverged after 25,000 years.
Both hypotheses gave concordant dates for the HTLV-2B group
divergence, about 25,000 years ago. In this hypothesis, the
evolution rate for HTLV-2 strains is about (4.7–1.9) 3 10-7
mutations/site/year. This rate is very low but may also explain
the fact that nearly identical strains were found in several Am-
erindian individuals originating from different populations,
including Wayuus from Colombia [48], Mapuche from Chile
[49], Seminole from Florida [50], and Guyami from Panama
[10]; these people are believed not to have had contact with each
other for at least several centuries. The molecular mechanisms of
such a phenomenon are unknown but could be in part linked to
the major clonal expansion of HTLV-2–infected cells, as dem-
onstrated in endemic populations [36].
With these data, we propose the following model/hypothesis
for HTLV-2 history. The genuine HTLV-2 appeared in Africa.
Some of them left Africa and became the ancestors of HTLV-
2A/C or HTLV-2B. The remaining virus became the HTLV-2D
strains. HTLV-2B–bearing populations may have migrated
through Asia and then separated into several subgroups: some
went to America, and others returned to Africa.
This model has 2 major limitations. We first suppose that
HTLV-2D is a genuine human retrovirus group and did not
arise from recent zoonoses [26]. Although our molecular
clock studies seem to argue in favor of such an idea, it is not
certain.
Second, this model would predict endemic foci of HTLV-2
throughout Asia, which has not been demonstrated as of yet.
The absence of detected endemic HTLV-2 could, however, be
explained. The discrete distribution of HTLV-2 makes it difficult
to make a definitive statement about the absence of infection in
a given area. Therefore, it is unlikely that the presence of pop-
ulations in Asia in which HTLV-2 is endemic would be revealed
after only a few studies. Moreover, the absence of the virus in
current populations does not mean that the virus was not
present at a previous time. Additional studies searching for
other HTLV-2 strains endemic in African populations and for
their simian counterparts will be crucial to yield new insights
into the origin, evolution, and modes of dissemination of these
retroviruses.
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Supplementary data are available at http://jid.oxfordjournals.org/
online.
Funding
This work was supported by the Institut Pasteur, by Agence Nationale de
Recherches sur le SIDA (ANRS). S.C. was supported by fellowships from la
Ligue Contre le Cancer and from the Association Virus Cancer Prevention.
R.M. is supported by INSERM. P.V.A. is supported by the Ministere de la
Recherche and the Pasteur Weizmann Association. We are grateful to Sanofi
Diagnostics Pasteur, which provided the ELISA tests.
References
1. Kalyanaraman VS, Sarngadharan MG, Robert-Guroff M, Miyoshi I,
Golde D, Gallo RC. A new subtype of human T-cell leukemia virus
(HTLV-II) associated with a T-cell variant of hairy cell leukemia.
Science 1982; 218:571–3.
2. Calattini S, Chevalier SA, Duprez R, et al. Discovery of a new human
T-cell lymphotropic virus (HTLV-3) in Central Africa. Retrovirology
2005; 2:30.
3. Wolfe ND, Heneine W, Carr JK, et al. Emergence of unique primate
T-lymphotropic viruses among central African bushmeat hunters. Proc
Natl Acad Sci U S A 2005; 102:7994–9.
4. Roucoux DF, Murphy EL. The epidemiology and disease outcomes of
human T-lymphotropic virus type II. AIDS Rev 2004; 6:144–54.
5. Bartman MT, Kaidarova Z, Hirschkorn D, et al. Long-term increases
in lymphocytes and platelets in human T-lymphotropic virus type II
infection. Blood 2008; 112:3995–4002.
6. Proietti FA, Carneiro-Proietti AB, Catalan-Soares BC, Murphy EL.
Global epidemiology of HTLV-I infection and associated diseases.
Oncogene 2005; 24:6058–68.
7. Mahieux R, Ibrahim F, Mauclere P, et al. Molecular epidemiology of 58
new African human T-cell leukemia virus type 1 (HTLV-1) strains:
identification of a new and distinct HTLV-1 molecular subtype in
Central Africa and in Pygmies. J Virol 1997; 71:1317–3.
8. Maloney EM, Biggar RJ, Neel JV, et al. Endemic human T cell
lymphotropic virus type II infection among isolated Brazilian
Amerindians. J Infect Dis 1992; 166:100–7.
9. Dube DK, Sherman MP, Saksena NK, et al. Genetic heterogeneity in
human T-cell leukemia/lymphoma virus type II. J Virol 1993; 67:1175–84.
10. Pardi D, Switzer WM, Hadlock KG, Kaplan JE, Lal RB, Folks TM.
Complete nucleotide sequence of an Amerindian human T-cell
lymphotropic virus type II (HTLV-II) isolate: identification of a variant
HTLV-II subtype b from a Guaymi Indian. J Virol 1993; 67:4659–64.
11. Hjelle B, Zhu SW, Takahashi H, Ijichi S, Hall WW. Endemic human
T cell leukemia virus type II infection in southwestern US Indians
involves two prototype variants of virus. J Infect Dis 1993; 168:737–40.
12. Lee H, Swanson P, Shorty VS, Zack JA, Rosenblatt JD, Chen IS. High
rate of HTLV-II infection in seropositive i.v. drug abusers in New
Orleans. Science 1989; 244:471–5.
13. Chironna M, Calabro ML, Quarto M, et al. HTLV-I and HTLV-II
infections in subjects at risk for HIV-I infection from southeastern Italy
(Apulia region). Int J Cancer 1996; 65:746–50.
14. Egan JF, O’Leary B, Lewis MJ, et al. High rate of human T lympho-
tropic virus type IIa infection in HIV type 1-infected intravenous drug
abusers in Ireland. AIDS Res Hum Retroviruses 1999; 15:699–705.
15. Vandamme AM, Salemi M, Desmyter J. The simian origins of the
pathogenic human T-cell lymphotropic virus type I. Trends Microbiol
1998; 6:477–83.
16. Mahieux R, Chappey C, Georges-Courbot MC, et al. Simian T-cell
lymphotropic virus type 1 from Mandrillus sphinx as a simian coun-
terpart of human T-cell lymphotropic virus type 1 subtype D. J Virol
1998; 72:10316–22.
17. Slattery JP, Franchini G, Gessain A. Genomic evolution, patterns of
global dissemination, and interspecies transmission of human and
simian T-cell leukemia/lymphotropic viruses. Genome Res 1999;
9:525–40.
18. Salemi M, Desmyter J, Vandamme AM. Tempo and mode of human
and simian T-lymphotropic virus (HTLV/STLV) evolution revealed
1322 d JID d Maucle`re et al.
 at Institut Pasteur, M
?diath?que scientifique on M
ay 6, 2011
jid.oxfordjournals.org
D
ow
nloaded from
 
by analyses of full-genome sequences. Mol Biol Evol 2000; 17:
374–86.
19. Biglione M, Vidan O, Mahieux R, et al. Seroepidemiological and
molecular studies of human T cell lymphotropic virus type II,
subtype b, in isolated groups of Mataco and Toba Indians of northern
Argentina. AIDS Res Hum Retroviruses 1999; 15:407–17.
20. Switzer WM, Pieniazek D, Swanson P, et al. Phylogenetic relationship
and geographic distribution of multiple human T-cell lymphotropic
virus type II subtypes. J Virol 1995; 69:621–32.
21. Eiraku N, Novoa P, da Costa Ferreira M, et al. Identification and
characterization of a new and distinct molecular subtype of human
T-cell lymphotropic virus type 2. J Virol 1996; 70:1481–92.
22. Tuppin P, Gessain A, Kazanji M, et al. Evidence in Gabon for an
intrafamilial clustering with mother-to-child and sexual transmission
of a new molecular variant of human T-lymphotropic virus type-II
subtype B. J Med Virol 1996; 48:22–32.
23. Goubau P, Liu HF, De Lange GG, Vandamme AM, Desmyter
J. HTLV-II seroprevalence in pygmies across Africa since 1970. AIDS
Res Hum Retroviruses 1993; 9:709–13.
24. Igarashi T, Yamashita M, Miura T, et al. Isolation and genomic analysis
of human T lymphotropic virus type II from Ghana. AIDS Res Hum
Retroviruses 1993; 9:1039–42.
25. Mauclere P, Gessain A, Garcia-Calleja JM, et al. HTLV-II in African
prostitutes from Cameroon. AIDS 1993; 7:1394–5.
26. Vandamme AM, Salemi M, Van Brussel M, et al. African origin of
human T-lymphotropic virus type 2 (HTLV-2) supported by a poten-
tial new HTLV-2d subtype in Congolese Bambuti Efe Pygmies. J Virol
1998; 72:4327–40.
27. Gessain A, Mauclere P, Froment A, et al. Isolation and molecular
characterization of a human T-cell lymphotropic virus type II
(HTLV-II), subtype B, from a healthy Pygmy living in a remote area of
Cameroon: an ancient origin for HTLV-II in Africa. Proc Natl Acad Sci
U S A 1995; 92:4041–5.
28. Salemi M, Lewis M, Egan JF, Hall WW, Desmyter J, Vandamme AM.
Different population dynamics of human T cell lymphotropic virus
type II in intravenous drug users compared with endemically infected
tribes. Proc Natl Acad Sci U S A 1999; 96:13253–8.
29. Koppert G, Dounais E, Froment A, Pasquet P. Food consumption in
three forest populations of the southern coastal Cameroon. In Hladik
CM, Hladik A, Linares O, Pagezy H, Semple A, Hadley M eds. Tropical
forests, people and food. Vol. 13. Paris: Parthe´non-UNESCO, 1993;
295–310.
30. Gessain A, Saal F, Gout O, et al. High human T-cell lymphotropic
virus type I proviral DNA load with polyclonal integration in pe-
ripheral blood mononuclear cells of French West Indian, Guianese,
and African patients with tropical spastic paraparesis. Blood 1990;
75:428–33.
31. Mahieux R, Horal P, Mauclere P, et al. Human T-cell lymphotropic
virus type 1 gag indeterminate Western blot patterns in Central Africa:
relationship to Plasmodium falciparum infection. J Clin Microbiol
2000; 38:4049–57.
32. Murphy EL, Mahieux R, de The G, et al. Molecular epidemiology of
HTLV-II among United States blood donors and intravenous drug
users: an age-cohort effect for HTLV-II RFLP type aO. Virology 1998;
242:425–34.
33. Drummond AJ, Ho SY, Phillips MJ, Rambaut A. Relaxed phylogenetics
and dating with confidence. PLoS Biol 2006; 4:e88.
34. Letourneur F, d’Auriol L, Dazza MC, et al. Complete nucleotide
sequence of an African human T-lymphotropic virus type II subtype
b isolate (HTLV-II-Gab): molecular and phylogenetic analysis. J Gen
Virol 1998; 79:269–77.
35. Li WH, Tanimura M. The molecular clock runs more slowly in man
than in apes and monkeys. Nature 1987; 326:93–6.
36. Gabet AS, Moules V, Sibon D, et al. Endemic versus epidemic viral
spreads display distinct patterns of HTLV-2b replication. Virology
2006; 345:13–21.
37. Feigal E, Murphy E, Vranizan K, et al. Human T cell lymphotropic
virus types I and II in intravenous drug users in San Francisco:
risk factors associated with seropositivity. J Infect Dis 1991; 164:36–42.
38. Quintana-Murci L, Quach H, Harmant C, et al. Maternal traces of
deep common ancestry and asymmetric gene flow between Pygmy
hunter-gatherers and Bantu-speaking farmers. Proc Natl Acad Sci U S A
2008; 105:1596–601.
39. Kajiyama W, Kashiwagi S, Hayashi J, et al. Study of seroconversion of
antibody to human T-cell lymphotropic virus type-I in children of
Okinawa, Japan. Microbiol Immunol 1990; 34:259–67.
40. Nerrienet E, Meertens L, Kfutwah A, Foupouapouognigni Y, Ayouba A,
Gessain A. Simian T cell leukaemia virus type I subtype B in a wild-
caught gorilla (Gorilla gorilla gorilla) and chimpanzee (Pan troglodytes
vellerosus) from Cameroon. J Gen Virol 2004; 85:25–9.
41. Nerrienet E, Meertens L, Kfutwah A, Foupouapouognigni Y, Gessain A.
Molecular epidemiology of simian T-lymphotropic virus (STLV) in
wild-caught monkeys and apes from Cameroon: a new STLV-1, related
to human T-lymphotropic virus subtype F, in a Cercocebus agilis. J Gen
Virol 2001; 82:2973–7.
42. Liegeois F, Lafay B, Switzer WM, et al. Identification and
molecular characterization of new STLV-1 and STLV-3 strains in
wild-caught nonhuman primates in Cameroon. Virology 2008;
371:405–17.
43. Mauclere P, Le Hesran JY, Mahieux R, et al. Demographic, ethnic,
and geographic differences between human T cell lymphotropic
virus (HTLV) type I-seropositive carriers and persons with HTLV-I
Gag-indeterminate Western blots in Central Africa. J Infect Dis 1997;
176:505–9.
44. Calattini S, Betsem E, Bassot S, et al. New strain of human T lym-
photropic virus (HTLV) type 3 in a Pygmy from Cameroon with
peculiar HTLV serologic results. J Infect Dis 2009; 199:561–4.
45. Dube DK, Dube S, Erensoy S, et al. Serological and nucleic acid analyses
for HIV and HTLV infection on archival human plasma samples from
Zaire. Virology 1994; 202:379–89.
46. Cassar O, Capuano C, Bassot S, et al. Human T lymphotropic virus
type 1 subtype C Melanesian genetic variants of the Vanuatu Archi-
pelago and Solomon Islands share a common ancestor. J Infect Dis
2007; 196:510–21.
47. Ibrahim F, de The G, Gessain A. Isolation and characterization of a new
simian T-cell leukemia virus type 1 from naturally infected celebes
macaques (Macaca tonkeana): complete nucleotide sequence and
phylogenetic relationship with the Australo-Melanesian human T-cell
leukemia virus type 1. J Virol 1995; 69:6980–93.
48. Switzer WM, Owen SM, Pieniazek DA, et al. Molecular analysis
of human T-cell lymphotropic virus type II from Wayuu Indians of
Colombia demonstrates two subtypes of HTLV-IIb. irus Genes 1995;
10:153–62.
49. Miura T, Yamashita M, Zaninovic V, et al. Molecular phylogeny of
human T-cell leukemia virus type I and II of Amerindians in Colombia
and Chile. J Mol Evol 1997; 44(suppl);S76–82.
50. Levine PH, Jacobson S, Elliott R, et al. HTLV-II infection in Florida
Indians. AIDS Res Hum Retroviruses 1993; 9:123–7.
Htlv-2 Is Endemic In Central Africa d JID d 1323
 at Institut Pasteur, M
?diath?que scientifique on M
ay 6, 2011
jid.oxfordjournals.org
D
ow
nloaded from
 
